(Q36478643)

14 August 2017

1 reference

title

Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas (English)

1 reference

convection-enhanced delivery

14 August 2017

0 references

author name string

Kenji Muro

series ordinal

1

1 reference

14 August 2017

Sunit Das

series ordinal

2

1 reference

14 August 2017

Jeffrey J Raizer

series ordinal

3

1 reference

14 August 2017

1 June 2006

1 reference

Technology in Cancer Research and Treatment

14 August 2017

1 reference

14 August 2017

5

1 reference

14 August 2017

3

1 reference

14 August 2017

201-213

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

14 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Current management of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

The vascularization of the human cerebellar cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Peptidases, peptides, and the mammalian blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Carrier mediated blood-brain barrier transport of choline and certain choline analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

The anatomy of astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

The Intracerebral Movement of Proteins Injected into Blood and Cerebrospinal Fluid of Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Bicarbonate transport across the frog choroid plexus and its control by cyclic nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Quantitative studies of the passage of different substances out of the cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

The mechanism of drainage of the cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Intracerebral chemotherapy: chronic microinfusion of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Transport of cisplatin in rat brain following microinfusion: an analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Pharmacokinetics of the carmustine implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

DTI-015 produces cures in T9 gliosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Tenascin expression in human glioma cell lines and normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Clearance of brain edema and macromolecules through the cortical extracellular space

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Convection-enhanced delivery of macromolecules in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malig

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Interleukin-13 receptor as a unique target for anti-glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

A circularly permuted recombinant interleukin 4 toxin with increased activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Transferrin receptor on endothelium of brain capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

DAB389EGF fusion protein therapy of refractory glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Successful combination of local CpG-ODN and radiotherapy in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Effect of the expression of transforming growth factor-beta 2 in primary human glioblastomas on immunosuppression and loss of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Neural stem cells and the origin of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

Drug metabolizing enzymes in the brain and cerebral microvessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500304

10.1177/153303460600500304

21 January 2018

Identifiers

DOI

1 reference

release_f72u4lmvxrcgjf3a3juxqq5mpa

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f72u4lmvxrcgjf3a3juxqq5mpa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference